SlideShare a Scribd company logo
Leukocyte Sirtuin 1 mRNA overexpression is associated
with Gestational Diabetes Mellitus (GDM)
Iga A. Turek
Department of Structural Biology
Medical University of Lodz
Supervisor: Prof. Lucyna A. Woźniak
Co-supervisor: Dr Marzena Wójcik
Presentation overview
1. Introduction
– Gestational Diabetes Mellitus (GDM)
– Sirtuin 1 (SIRT1)
1. Project aims
2. Methodology
3. Results
4. Conclusions
Slide 2 from 11
Introduction
Slide 3 from 11
 GDM (Gestational Diabetes Mellitus)
 glucose intolerance with onset during
pregnancy.
 prevalence: up to 17%
 SIRT1 (Sirtuin 1)
 NAD+
-dependent histone deacetylase
 maintenance of glucose and lipid
homeostasis
 regulation of insulin secretion
 over 20 known substrates
Project aims:
to determine SIRT1 mRNA expression in leukocytes of GDM women
at 24-33 weeks of pregnancy
to correlate changes in leukocyte SIRT1 expression with clinical
characteristics of subjects
Slide 4 from 11
Methodology
Slide 5 from 11
RNA isolation
leukocytes separation
GDM (the HAPO criteria)
n=135
control group (NGT)
n=52
venous blood
leukocytes
RNA
RBC lysis buffer in hypotonic
conditions
qRT-PCR
SIRT1
Primer sequence 5’→3’ cDNA amplicon size
Reverse: TGTGACAGAGAGATGGCTGG
142Forward: GCTCGCCTTGCTGTAGACTT
Results
SIRT1 expression
 leukocyte SIRT1 mRNA expression was 1.7-fold higher in GDM vs.
NGT pregnant women
Slide 7 from 11
Correlations of SIRT1 expression
Positive correlations of SIRT1 expression with:
A.glucose concentration at 2 h of OGTT in the whole study group (NGT + GDM)
B.HDL-cholesterol in NGT group
Slide 8 from 11
Results:
 increased leukocyte SIRT1 mRNA expression in the GDM women
 association of leukocyte SIRT1 overexpression with hyperglycemia in
diabetic subjects
 positive correlation between leukocyte SIRT1 expression and HDL-
cholesterol in health pregnant women
Slide 9 from 11
Conclusions:
 association of GDM with a change in leukocyte SIRT1 expression at its
gene level
 leukocyte SIRT1 expression is related to hyperglycemic conditions
 potential protective role of leukocyte SIRT1 against CVD in healthy
pregnancy
Slide 10 from 11
Thank you
for your attention

More Related Content

Similar to Doctoral Students Session, Turek Iga, Leukocyte Sirtuin 1 mRNA overexpression is associated with Gestational Diabetes Mellitus (GDM)

Gdm ho presentation
Gdm ho presentationGdm ho presentation
Gdm ho presentation
limgengyan
 
Diabete e Preeclampsia - Federico Mecacci
Diabete e Preeclampsia - Federico MecacciDiabete e Preeclampsia - Federico Mecacci
Diabete e Preeclampsia - Federico Mecacci
robertobottino1
 
Herbal therapies for type 2 diabetes mellitus
Herbal therapies for type 2 diabetes mellitusHerbal therapies for type 2 diabetes mellitus
Herbal therapies for type 2 diabetes mellitus
Dwie Craph
 

Similar to Doctoral Students Session, Turek Iga, Leukocyte Sirtuin 1 mRNA overexpression is associated with Gestational Diabetes Mellitus (GDM) (20)

FCPD by Dr Shahjada Seim
FCPD by Dr Shahjada SeimFCPD by Dr Shahjada Seim
FCPD by Dr Shahjada Seim
 
41392_2022_Article_1149.pdf
41392_2022_Article_1149.pdf41392_2022_Article_1149.pdf
41392_2022_Article_1149.pdf
 
Iroijmas107
Iroijmas107Iroijmas107
Iroijmas107
 
Pancreatitis
PancreatitisPancreatitis
Pancreatitis
 
Role of lnk in insulin resistance
Role of lnk in insulin resistanceRole of lnk in insulin resistance
Role of lnk in insulin resistance
 
Type 2 Diabetes Mellitus - Pathophysiology
Type 2 Diabetes Mellitus - PathophysiologyType 2 Diabetes Mellitus - Pathophysiology
Type 2 Diabetes Mellitus - Pathophysiology
 
LEADER Trial - Liraglutide in Diabetes....Cardiovascular outcome
LEADER Trial - Liraglutide in Diabetes....Cardiovascular outcomeLEADER Trial - Liraglutide in Diabetes....Cardiovascular outcome
LEADER Trial - Liraglutide in Diabetes....Cardiovascular outcome
 
Diabetes types and treatment
Diabetes types and treatmentDiabetes types and treatment
Diabetes types and treatment
 
Gdm ho presentation
Gdm ho presentationGdm ho presentation
Gdm ho presentation
 
Diabete e Preeclampsia - Federico Mecacci
Diabete e Preeclampsia - Federico MecacciDiabete e Preeclampsia - Federico Mecacci
Diabete e Preeclampsia - Federico Mecacci
 
PRE-ECLAMPSIA ECLAMPSIA, BEST PRACTICES.pptx
PRE-ECLAMPSIA ECLAMPSIA, BEST PRACTICES.pptxPRE-ECLAMPSIA ECLAMPSIA, BEST PRACTICES.pptx
PRE-ECLAMPSIA ECLAMPSIA, BEST PRACTICES.pptx
 
Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...
Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...
Revisión: Resistencia a la insulina y el síndrome de ovario poliquístico. Una...
 
Gluten Revealed!
Gluten Revealed!  Gluten Revealed!
Gluten Revealed!
 
Molecular basis of diabetes
Molecular basis of diabetesMolecular basis of diabetes
Molecular basis of diabetes
 
DIABETES IN PREGNANCY FOR MIDWIVES_ .pptx
DIABETES IN PREGNANCY FOR MIDWIVES_ .pptxDIABETES IN PREGNANCY FOR MIDWIVES_ .pptx
DIABETES IN PREGNANCY FOR MIDWIVES_ .pptx
 
Presentation pre ph d amreen
Presentation pre ph d   amreenPresentation pre ph d   amreen
Presentation pre ph d amreen
 
Awakush
AwakushAwakush
Awakush
 
DM Pathogenesis.pdf
DM Pathogenesis.pdfDM Pathogenesis.pdf
DM Pathogenesis.pdf
 
Herbal therapies for type 2 diabetes mellitus
Herbal therapies for type 2 diabetes mellitusHerbal therapies for type 2 diabetes mellitus
Herbal therapies for type 2 diabetes mellitus
 
Pores and cores of new anti diabetic therapy
Pores and cores of new anti diabetic therapyPores and cores of new anti diabetic therapy
Pores and cores of new anti diabetic therapy
 

Doctoral Students Session, Turek Iga, Leukocyte Sirtuin 1 mRNA overexpression is associated with Gestational Diabetes Mellitus (GDM)

  • 1. Leukocyte Sirtuin 1 mRNA overexpression is associated with Gestational Diabetes Mellitus (GDM) Iga A. Turek Department of Structural Biology Medical University of Lodz Supervisor: Prof. Lucyna A. Woźniak Co-supervisor: Dr Marzena Wójcik
  • 2. Presentation overview 1. Introduction – Gestational Diabetes Mellitus (GDM) – Sirtuin 1 (SIRT1) 1. Project aims 2. Methodology 3. Results 4. Conclusions Slide 2 from 11
  • 3. Introduction Slide 3 from 11  GDM (Gestational Diabetes Mellitus)  glucose intolerance with onset during pregnancy.  prevalence: up to 17%  SIRT1 (Sirtuin 1)  NAD+ -dependent histone deacetylase  maintenance of glucose and lipid homeostasis  regulation of insulin secretion  over 20 known substrates
  • 4. Project aims: to determine SIRT1 mRNA expression in leukocytes of GDM women at 24-33 weeks of pregnancy to correlate changes in leukocyte SIRT1 expression with clinical characteristics of subjects Slide 4 from 11
  • 5. Methodology Slide 5 from 11 RNA isolation leukocytes separation GDM (the HAPO criteria) n=135 control group (NGT) n=52 venous blood leukocytes RNA RBC lysis buffer in hypotonic conditions qRT-PCR SIRT1 Primer sequence 5’→3’ cDNA amplicon size Reverse: TGTGACAGAGAGATGGCTGG 142Forward: GCTCGCCTTGCTGTAGACTT
  • 7. SIRT1 expression  leukocyte SIRT1 mRNA expression was 1.7-fold higher in GDM vs. NGT pregnant women Slide 7 from 11
  • 8. Correlations of SIRT1 expression Positive correlations of SIRT1 expression with: A.glucose concentration at 2 h of OGTT in the whole study group (NGT + GDM) B.HDL-cholesterol in NGT group Slide 8 from 11
  • 9. Results:  increased leukocyte SIRT1 mRNA expression in the GDM women  association of leukocyte SIRT1 overexpression with hyperglycemia in diabetic subjects  positive correlation between leukocyte SIRT1 expression and HDL- cholesterol in health pregnant women Slide 9 from 11
  • 10. Conclusions:  association of GDM with a change in leukocyte SIRT1 expression at its gene level  leukocyte SIRT1 expression is related to hyperglycemic conditions  potential protective role of leukocyte SIRT1 against CVD in healthy pregnancy Slide 10 from 11
  • 11. Thank you for your attention